David DURACHER joined ADOCIA in 2005 and hold a position of Director of Pharmaceutical development.

He holds a doctorate in polymer physical chemistry. His dissertation, which was financed by BioMerieux, was in the field of biomedical diagnostics, at the interface between the science of polymers and biology.

15+ years of experience in the drug delivery and drug development of sterile biologics and peptides

Working on project from research and innovation to pharmaceutical development of clinical stage project (from preclinical to Phase III)

Strong experience and expertise in CM&C of Drug Substance and biopharmaceutical Drug Product (from peptides to biologics)

Lead contract negotiations and technical supervision of CMOs for custom manufacturing of DS (API, peptides, enzymatic process and biologics), and DP (fill & finish) under cGMP regulation. Strategic sourcing and supply of API and critical raw material. Development of Device for Combination products (auto-injectors and pens)

International working environment (EU, USA, India and China)